新型装置腹部按压-减压联合胸外按压CPR:这种联合CPR技术能否改善预后
本研究为单中心、前瞻性随机试验,纳入278例院外心脏骤停(OHCA)患者,随机分为STD-CPR组(n=135)和CO-CPR组(n=143),比较自主循环恢复(ROSC)、存活至入院、存活至出院的比例,并在随访结束时用Kaplan-Meier分析及log-rank检验比较生存曲线。结果显示,CO-CPR组与STD-CPR组ROSC比例[31/135(23.0%)对35/143(24.5%)]和存活至入院比例[28/135(20.7%)对33/143(23.1%)]差异无统计学意义;但CO-CPR组存活至出院比例[16/135(11.9%)对7/143(4.9%)]差异有统计学意义。CO-CPR组9例(6.7%)和STD组2例(1.4%)达脑功能分级(CPC)良好神经功能结局,差异有统计学意义(P=0.003)。Kaplan-Meier曲线显示CO-CPR组随访结束时生存获益优于STD-CPR组(log-rank P=0.007)。结论认为CO-CPR在OHCA患者生存获益方面优于STD-CPR。
要点
- 在OHCA患者中,CO-CPR组存活至出院16/135(11.9%),STD-CPR组7/143(4.9%),两组差异有统计学意义。
- CO-CPR组良好神经功能结局(CPC量表)9例(6.7%),STD组2例(1.4%),差异有统计学意义(P=0.003)。
- CO-CPR组与STD-CPR组ROSC比例[31/135(23.0%)对35/143(24.5%)]和存活至入院比例[28/135(20.7%)对33/143(23.1%)]差异无统计学意义。
- Kaplan-Meier生存曲线显示CO-CPR组随访结束时生存获益优于STD-CPR组(log-rank P=0.007)。
- 该试验为单中心、前瞻性随机试验,共278例OHCA患者随机分组,结局评估采用盲法。
适用人群与场景
- 院外心脏骤停(OHCA)患者,共筛查297例连续患者,最终278例随机分组。
处置流程与药物剂量
- CO-CPR组采用新型装置进行胸外按压联合腹部按压-减压心肺复苏;STD-CPR组采用标准心肺复苏。
研究设计与关键结果
- 研究类型:单中心、前瞻性、随机试验,结局评估采用盲法;筛查297例连续OHCA患者,278例随机分为STD-CPR组(n=135)和CO-CPR组(n=143)。
- 主要终点:CO-CPR组与STD-CPR组ROSC比例[31/135(23.0%)对35/143(24.5%)]差异无统计学意义;存活至入院比例[28/135(20.7%)对33/143(23.1%)]差异无统计学意义。
- 存活至出院:CO-CPR组16/135(11.9%)对STD-CPR组7/143(4.9%),差异有统计学意义。
- 神经功能结局:CO-CPR组9例(6.7%)对STD组2例(1.4%)达CPC量表良好神经功能结局,差异有统计学意义(P=0.003)。
- Kaplan-Meier分析:随访结束时CO-CPR组生存获益优于STD-CPR组(log-rank P=0.007)。
证据类型、等级与局限
- 证据类型:单中心、前瞻性、随机试验,结局评估采用盲法。
- 试验注册:中国临床试验注册中心,注册号ChiCTR2100049581,注册日期2021年7月30日,回顾性注册。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于院外心脏骤停患者,CO-CPR在生存获益方面优于STD-CPR。
指南或共识出处
- 中国临床试验注册中心,注册号ChiCTR2100049581。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: This study was designed to compare the outcomes of standard cardiopulmonary resuscitation (STD-CPR) and combined chest compression and abdominal compression-decompression cardiopulmonary resuscitation (CO-CPR) with a new device following out-of-hospital cardiac arrest (OHCA). Moreover, we investigated whether patient prognosis improved with this combination treatment.
METHODS: This trial was a single-centre, prospective, randomized trial, and a blinded assessment of the outcomes was performed. A total of 297 consecutive patients with OHCA were initially screened, and 278 were randomized to the STD-CPR group (n = 135) or the CO-CPR group (n = 143). We compared the proportions of patients who achieved a return of spontaneous circulation (ROSC), survived to hospital admission and survived to hospital discharge. In addition, we also performed the Kaplan-Meier analysis with a log-rank test at the end of the follow-up period to compare the survival curves of the two groups.
RESULTS: The differences were not statistically significant in the proportion of patients who achieved ROSC [31/135 (23.0%) versus 35/143 (24.5%)] and survived to hospital admission [28/135 (20.7%) versus 33/143 (23.1%)] between the CO-CPR group and STD-CPR group. However, there was a significant difference in the proportion of patients who survived to hospital discharge [16/135 (11.9%) versus 7/143 (4.9%)] between the two groups. Nine patients (6.7%) in the CO-CPR group and 2 patients (1.4%) in the STD group showed good neurological outcomes according to the cerebral performance category (CPC) scale score, and the difference was statistically significant (P = 0.003). The Kaplan-Meier curves showed that the patients in the CO-CPR group achieved better survival benefits than those in the STD-CPR group at the end of the follow-up period (log-rank P = 0.007).
CONCLUSION: CO-CPR was more beneficial than STD-CPR in terms of survival benefits in patients who have suffered out-of-hospital cardiac arrest. Trial registration Chinese Clinical Trial Registry, registered number: ChiCTR2100049581 . Registered 30 July 2021- Retrospectively registered. http://www.medresman.org.cn/uc/index.aspx .
参考来源
- Li H, Wang C, Zhang H, et al. Evaluation of abdominal compression-decompression combined with chest compression CPR performed by a new device: Is the prognosis improved after this combination CPR technique? Scand J Trauma Resusc Emerg Med. 2022. PMID: 35964100. doi:10.1186/s13049-022-01036-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。